Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

L. Bello, L. Piva, A. Barp, A. Taglia, E. Picillo, G. Vasco, M. Pane, S. C. Previtali, Y. Torrente, E. Gazzerro, M. C. Motta, G. S. Grieco, S. Napolitano, F. Magri, A. D'Amico, G. Astrea, S. Messina, M. Sframeli, G. L. Vita, P. Boffi, T. Mongini, A. Ferlini, F. Gualandi, G. Soraru', M. Ermani, G. Vita, R. Battini, E. Bertini, G. P. Comi, A. Berardinelli, C. Minetti, C. Bruno, E. Mercuri, L. Politano, C. Angelini, E. P. Hoffman, E. Pegoraro
  • Neurology, June 2012, Wolters Kluwer Health
  • DOI: 10.1212/wnl.0b013e31825f04ea

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1212/wnl.0b013e31825f04ea

The following have contributed to this page: Prof Corrado Angelini